Detalhe da pesquisa
1.
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma.
Int J Mol Sci;
23(9)2022 Apr 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35562974
2.
A model for identification of potential phase-separated proteins based on protein sequence, structure and cellular distribution.
Int J Biol Macromol;
243: 125196, 2023 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37285890
3.
Tyrosine metabolic reprogramming coordinated with the tricarboxylic acid cycle to drive glioma immune evasion by regulating PD-L1 expression.
Ibrain;
9(2): 133-147, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37786553
4.
Facile Photoresponsive Actuators Based on Ferrocene-Doped Poly(butyl methacrylate).
ACS Appl Mater Interfaces;
15(32): 38846-38856, 2023 Aug 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37537978
5.
Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer.
Expert Opin Ther Targets;
27(8): 733-743, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37571851
6.
PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1.
MedComm (2020);
4(2): e245, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36999124
7.
PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism.
Acta Pharm Sin B;
13(1): 157-173, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36815049
8.
Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma.
Biomedicines;
10(2)2022 Jan 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35203444
9.
The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology.
Front Pharmacol;
13: 934729, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35814224
10.
PRIM2 Promotes Cell Cycle and Tumor Progression in p53-Mutant Lung Cancer.
Cancers (Basel);
14(14)2022 Jul 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35884433
11.
Interruption of bile acid enterohepatic circulation inhibits glycogen synthesis and promotes hepatocellular carcinoma progression.
Genes Dis;
10(6): 2218-2221, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37554198
12.
FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1.
Clin Transl Med;
12(3): e772, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35297218